International audienceSynthetic amorphous silica nanoparticles (SAS) are among the most widely produced and used nanomaterials, but little is known about their carcinogenic potential. This study aims to evaluate the ability of four different SAS, two precipitated, NM-200 and NM-201, and two pyrogenic, NM-202 and NM-203, to induce the transformation process. For this, we used the recently developed in vitro Bhas 42 cell transformation assay (CTA). The genome of the transgenic Bhas 42 cells contains several copies of the v-Ha-ras gene, making them particularly sensitive to tumor-promoter agents. The Bhas 42 CTA, which includes an initiation assay and a promotion assay, was validated in our laboratory using known soluble carcinogenic substances. Its suitability for particle-type substances was verified by using quartz Min-U-Sil 5 (Min-U-Sil) and diatomaceous earth (DE) microparticles. As expected given their known transforming properties, Min-U-Sil responded positively in the Bhas 42 CTA and DE responded negatively. Transformation assays were performed with SAS at concentrations ranging from 2 ”g/cm 2 to 80 ”g/cm 2. Results showed that all SAS have the capacity to induce transformed foci, interestingly only in the promotion assay, suggesting a mode of action similar to tumor-promoter substances. NM-203 exhibited transforming activity at a lower concentration than the other SAS. In conclusion, this study showed for the first time the transforming potential of different SAS, which act as tumor-promoter substances in the Bhas 42 model of cell transformation.Les nanoparticules de silice amorphes de synthĂšse (SAS) sont les nanomatĂ©riaux les plus produits et les plus utilisĂ©s dans le monde, mais leur potentiel cancĂ©rogĂšne est peu Ă©tudiĂ©. Cette Ă©tude avait pour but dâĂ©valuer la capacitĂ© de quatre diffĂ©rentes SAS, deux sous forme prĂ©cipitĂ©e, NM-200 et NM-201 et deux sous forme pyrogĂ©nĂ©e, NM-202 et NM-203, dâinduire des processus de cancĂ©rogĂ©nĂšse. Pour cela, nous avons utilisĂ© lâessai de transformation sur les cellules Bhas 42 (Bhas 42 CTA) qui a Ă©tĂ© rĂ©cemment dĂ©veloppĂ©. Le gĂ©nome des cellules Bhas 42 transgĂ©niques contient plusieurs copies du gĂšne v-Ha-ras, ce qui leur confĂšre les caractĂ©ristiques de cellules « initiĂ©es » et les rend particuliĂšrement sensibles aux agents promoteurs de tumeur. Le Bhas 42 CTA, qui inclut un essai dâinitiation et un essai de promotion, a Ă©tĂ© validĂ© dans notre laboratoire en utilisant des agents cancĂ©rogĂšnes solubles connus. Son adaptabilitĂ© pour des substances de type particule a Ă©tĂ© vĂ©rifiĂ© en utilisant des microparticules de quartz Min-U-Sil 5 (Min-U-Sil) et de terre de diatomĂ©e (DE). Comme attendu dâaprĂšs leur propriĂ©tĂ© transformante connue, le Min-U-Sil a rĂ©pondu positivement et la DE nĂ©gativement au Bhas 42 CTA. Les essais de transformation ont Ă©tĂ© rĂ©alisĂ©s Ă des concentrations de SAS sâĂ©talant de 2 ”g/cm2 Ă 80 ”g/cm2. Les rĂ©sultats montrent que toutes les SAS ont la capacitĂ© dâinduire des foyers de transformation et de maniĂšre intĂ©ressante, uniquement dans lâessai de promotion, suggĂ©rant...